NR4A nuclear receptors are orphans but not lonesome

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2543-2555

  Kurakula, Kondababu ^a   Koenis, Duco S ^a   van Tiel, Claudia M ^a   de Vries, Carlie J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

NOR 1; NR4A; Nuclear receptor; Nur77; Nurr1; Protein protein interaction

Indexed keywords

CELL NUCLEUS RECEPTOR; DOUBLE STRANDED DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KIDNEY INJURY MOLECULE 1; LIM PROTEIN; NUCLEAR RECEPTOR NOR1; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEASOME; PROTEIN BCL 2; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STEROID HORMONE; STEROID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; HORMONE SYNTHESIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 84905401616     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.010     Document Type: Review

References (108)

1. Hamers A.A., Hanna R.N., Nowyhed H., Hedrick C.C., de Vries C.J. NR4A nuclear receptors in immunity and atherosclerosis. Curr. Opin. Lipidol. 2013, 24:381-385.
2. Philips A., Lesage S., Gingras R., Maira M.H., Gauthier Y., Hugo P., Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 1997, 17:5946-5951.
3. Maira M., Martens C., Philips A., Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 1999, 19:7549-7557.
4. Mynard V., Latchoumanin O., Guignat L., Devin-Leclerc J., Bertagna X., Barre B., Fagart J., Coqueret O., Catelli M.G. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter. Mol. Endocrinol. 2004, 18:2997-3010.
5. Martin L.J., Tremblay J.J. Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1. J. Mol. Endocrinol. 2008, 41:165-175.
6. Martin L.J., Tremblay J.J. The nuclear receptors NUR77 and SF1 play additive roles with c-JUN through distinct elements on the mouse Star promoter. J. Mol. Endocrinol. 2009, 42:119-129.
7. Lee S.Y., Gong E.Y., Hong C.Y., Kim K.H., Han J.S., Ryu J.C., Chae H.Z., Yun C.H., Lee K. ROS inhibit the expression of testicular steroidogenic enzyme genes via the suppression of Nur77 transactivation. Free Radic. Biol. Med. 2009, 47:1591-1600.
8. Song K.H., Park Y.Y., Park K.C., Hong C.Y., Park J.H., Shong M., Lee K., Choi H.S. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol. Endocrinol. 2004, 18:1929-1940.
9. Bilodeau S., Vallette-Kasic S., Gauthier Y., Figarella-Branger D., Brue T., Berthelet F., Lacroix A., Batista D., Stratakis C., Hanson J., Meij B., Drouin J. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 2006, 20:2871-2886.
10. Martens C., Bilodeau S., Maira M., Gauthier Y., Drouin J. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol. Endocrinol. 2005, 19:885-897.
11. Philips A., Maira M., Mullick A., Chamberland M., Lesage S., Hugo P., Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 1997, 17:5952-5959.
12. Song C.H., Gong E.Y., Park J., Lee K. Testicular steroidogenesis is locally regulated by androgen via suppression of Nur77. Biochem. Biophys. Res. Commun. 2012, 422:327-332.
13. Lee S.Y., Park E., Kim S.C., Ahn R.S., Ko C., Lee K. ERalpha/E2 signaling suppresses the expression of steroidogenic enzyme genes via cross-talk with orphan nuclear receptor Nur77 in the testes. Mol. Cell. Endocrinol. 2012, 362:91-103.
14. Hong C.Y., Park J.H., Ahn R.S., Im S.Y., Choi H.S., Soh J., Mellon S.H., Lee K. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol. Cell. Biol. 2004, 24:2593-2604.
15. Wansa K.D., Harris J.M., Muscat G.E. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem. 2002, 277:33001-33011.
16. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 1995, 9:769-782.
17. Cao X., Liu W., Lin F., Li H., Kolluri S.K., Lin B., Han Y.H., Dawson M.I., Zhang X.K. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 2004, 24:9705-9725.
18. Mathisen G.H., Fallgren A.B., Strom B.O., Boldingh Debernard K.A., Mohebi B.U., Paulsen R.E. Delayed translocation of NGFI-B/RXR in glutamate stimulated neurons allows late protection by 9-cis retinoic acid. Biochem. Biophys. Res. Commun. 2011, 414:90-95.
19. Lee Y.W., Terranova C., Birkaya B., Narla S., Kehoe D., Parikh A., Dong S., Ratzka A., Brinkmann H., Aletta J.M., Tzanakakis E.S., Stachowiak E.K., Claus P., Stachowiak M.K. A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. J. Cell. Biochem. 2012, 113:2920-2936.
20. Lin X.F., Zhao B.X., Chen H.Z., Ye X.F., Yang C.Y., Zhou H.Y., Zhang M.Q., Lin S.C., Wu Q. RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells. J. Cell Sci. 2004, 117:5609-5621.
21. Zhao W.X., Tian M., Zhao B.X., Li G.D., Liu B., Zhan Y.Y., Chen H.Z., Wu Q. Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha. Mol. Endocrinol. 2007, 21:2877-2889.
22. Kang H.J., Song M.R., Lee S.K., Shin E.C., Choi Y.H., Kim S.J., Lee J.W., Lee M.O. Retinoic acid and its receptors repress the expression and transactivation functions of Nur77: a possible mechanism for the inhibition of apoptosis by retinoic acid. Exp. Cell Res. 2000, 256:545-554.
23. Zhang X.K. Targeting Nur77 translocation. Expert Opin. Ther. Targets 2007, 11:69-79.
24. Katagiri Y., Takeda K., Yu Z.X., Ferrans V.J., Ozato K., Guroff G. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol. 2000, 2:435-440.
25. Papac-Milicevic N., Breuss J.M., Zaujec J., Ryban L., Plyushch T., Wagner G.A., Fenzl S., Dremsek P., Cabaravdic M., Steiner M., Glass C.K., Binder C.J., Uhrin P., Binder B.R. The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circ. Res. 2012, 110:e50-e63.
26. Wu Q., Li Y., Liu R., Agadir A., Lee M.O., Liu Y., Zhang X. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J. 1997, 16:1656-1669.
27. Moll U.M., Marchenko N., Zhang X.K. p53 and Nur77. Oncogene 2006, 25:4725-4743.
28. Yeo M.G., Yoo Y.G., Choi H.S., Pak Y.K., Lee M.O. Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells. Mol. Endocrinol. 2005, 19:950-963.
29. Pei L., Waki H., Vaitheesvaran B., Wilpitz D.C., Kurland I.J., Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat. Med. 2006, 12:1048-1055.
30. Pols T.W., Ottenhoff R., Vos M., Levels J.H., Quax P.H., Meijers J.C., Pannekoek H., Groen A.K., de Vries C.J. Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem. Biophys. Res. Commun. 2008, 366:910-916.
31. Wu H., Lin Y.Y., Li W.G., Sun Z., Gao W.W., Zhang H.P., Xie L., Jiang F.Q., Qin B., Yan T.D., Chen L.Q., Zhao Y., Cao X.H., Wu Y., Lin B.Z., Zhou H., Wong A.S.T., Zhang X.K., Zeng J.Z. Regulation of Nur77 expression by beta-catenin and its mitogenic effect in colon cancer cells. FASEB J. 2011, 25:192-205.
32. Chen H.Z., Liu Q.F., Li L., Wang W.J., Yao L.M., Yang M., Liu B., Chen W., Zhan Y.Y., Zhang M.Q., Cai J.C., Zheng Z.H., Lin S.C., Li B.A., Wu Q. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Gut 2012, 61:714-724.
33. Sun Z., Cao X., Jiang M.M., Qiu Y., Zhou H., Chen L., Qin B., Wu H., Jiang F., Chen J., Liu J., Dai Y., Chen H.F., Hu Q.Y., Wu Z., Zeng J.Z., Yao X.S., Zhang X.K. Inhibition of beta-catenin signaling by nongenomic action of orphan nuclear receptor Nur77. Oncogene 2012, 31:2653-2667.
34. Lee S.O., Chintharlapalli S., Liu S., Papineni S., Cho S.D., Yoon K., Safe S. p21 Expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells. Mol. Cancer Res. 2009, 7:1169-1178.
35. Lee S.O., Abdelrahim M., Yoon K., Chintharlapalli S., Papineni S., Kim K., Wang H., Safe S. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 2010, 70:6824-6836.
36. Wu W.S., Xu Z.X., Ran R., Meng F., Chang K.S. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene 2002, 21:3925-3933.
37. Jehn B.M., Bielke W., Pear W.S., Osborne B.A. Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J. Immunol. 1999, 162:635-638.
38. Zhao B.X., Chen H.Z., Lei N.Z., Li G.D., Zhao W.X., Zhan Y.Y., Liu B., Lin S.C., Wu Q. p53 Mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J. 2006, 25:5703-5715.
39. Yoo Y.G., Yeo M.G., Kim D.K., Park H., Lee M.O. Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J. Biol. Chem. 2004, 279:53365-53373.
40. Kim B.Y., Kim H., Cho E.J., Youn H.D. Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation. Exp. Mol. Med. 2008, 40:71-83.
41. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 2011, 12:778-785.
42. Harant H., Lindley I.J. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Nucleic Acids Res. 2004, 32:5280-5290.
43. Kelly S.N., McKenna T.J., Young L.S. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex. J. Endocrinol. 2005, 186:33-42.
44. Maira M., Martens C., Batsche E., Gauthier Y., Drouin J. Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase a pathway and AF-1-dependent coactivator recruitment. Mol. Cell. Biol. 2003, 23:763-776.
45. Batsche E., Desroches J., Bilodeau S., Gauthier Y., Drouin J. Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J. Biol. Chem. 2005, 280:19746-19756.
46. Kang S.A., Na H., Kang H.J., Kim S.H., Lee M.H., Lee M.O. Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1. Biochem. Pharmacol. 2010, 80:867-873.
47. Li G.D., Fang J.X., Chen H.Z., Luo J., Zheng Z.H., Shen Y.M., Wu Q. Negative regulation of transcription coactivator p300 by orphan receptor TR3. Nucleic Acids Res. 2007, 35:7348-7359.
48. Rambaud J., Desroches J., Balsalobre A., Drouin J. TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. J. Biol. Chem. 2009, 284:14147-14156.
49. Lei N.Z., Zhang X.Y., Chen H.Z., Wang Y., Zhan Y.Y., Zheng Z.H., Shen Y.M., Wu Q. A feedback regulatory loop between methyltransferase PRMT1 and orphan receptor TR3. Nucleic Acids Res. 2009, 37:832-848.
50. Park K.C., Song K.H., Chung H.K., Kim H., Kim D.W., Song J.H., Hwang E.S., Jung H.S., Park S.H., Bae I., Lee I.K., Choi H.S., Shong M. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol. Endocrinol. 2005, 19:12-24.
51. Qamar I., Gong E.Y., Kim Y., Song C.H., Lee H.J., Chun S.Y., Lee K. Anti-steroidogenic factor ARR19 inhibits testicular steroidogenesis through the suppression of Nur77 transactivation. J. Biol. Chem. 2010, 285:22360-22369.
52. Sohn Y.C., Kwak E., Na Y.J., Lee J.W., Lee S.K. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J. Biol. Chem. 2001, 276:43734-43739.
53. Woronicz J.D., Lina A., Calnan B.J., Szychowski S., Cheng L., Winoto A. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 1995, 15:6364-6376.
54. Lee S.K., Anzick S.L., Choi J.E., Bubendorf L., Guan X.Y., Jung Y.K., Kallioniemi O.P., Kononen J., Trent J.M., Azorsa D., Jhun B.H., Cheong J.H., Lee Y.C., Meltzer P.S., Lee J.W. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. 1999, 274:34283-34293.
55. McConkey D.J., Jondal M., Orrenius S. The regulation of apoptosis in thymocytes. Biochem. Soc. Trans. 1994, 22:606-610.
56. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., Dawson M.I., Reed J.C., Zhang X.K. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004, 116:527-540.
57. Thompson J., Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J. Exp. Med. 2008, 205:1029-1036.
58. Kolluri S.K., Zhu X., Zhou X., Lin B., Chen Y., Sun K., Tian X., Town J., Cao X., Lin F., Zhai D., Kitada S., Luciano F., O'Donnell E., Cao Y., He F., Lin J., Reed J.C., Satterthwait A.C., Zhang X.K. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 2008, 14:285-298.
59. Kurakula K., van der Wal E., Geerts D., van Tiel C.M., de Vries C.J. FHL2 protein is a novel co-repressor of nuclear receptor Nur77. J. Biol. Chem. 2011, 286:44336-44343.
60. Balasubramanian S., Kota S.K., Kuchroo V.K., Humphreys B.D., Strom T.B. TIM family proteins promote the lysosomal degradation of the nuclear receptor NUR77. Sci. Signal. 2012, 5:ra90.
61. Zhou F., Drabsch Y., Dekker T.J., de Vinuesa A.G., Li Y., Hawinkels L.J., Sheppard K.A., Goumans M.J., Luwor R.B., de Vries C.J., Mesker W.E., Tollenaar R.A., Devilee P., Lu C.X., Zhu H., Zhang L., Dijke P.T. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-beta signalling. Nat. Commun. 2014, 5:3388.
62. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., Thibodeau S.N. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 2000, 26:146-147.
63. Chen H.Z., Li L., Wang W.J., Du X.D., Wen Q., He J.P., Zhao B.X., Li G.D., Zhou W., Xia Y., Yang Q.Y., Hew C.L., Liou Y.C., Wu Q. Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis. Oncogene 2012, 31:2876-2887.
64. van Tiel C.M., Kurakula K., Koenis D.S., van der Wal E., de Vries C.J. Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability. Biochim. Biophys. Acta 2012, 1823:1894-1904.
65. Liu B., Wu J.F., Zhan Y.Y., Chen H.Z., Zhang X.Y., Wu Q. Regulation of the orphan receptor TR3 nuclear functions by c-Jun N terminal kinase phosphorylation. Endocrinology 2007, 148:34-44.
66. Smith G.C., Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 1999, 13:916-934.
67. Zhao B.X., Chen H.Z., Du X.D., Luo J., He J.P., Wang R.H., Wang Y., Wu R., Hou R.R., Hong M., Wu Q. Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation. Mol. Endocrinol. 2011, 25:1337-1350.
68. Malewicz M., Kadkhodaei B., Kee N., Volakakis N., Hellman U., Viktorsson K., Leung C.Y., Chen B., Lewensohn R., van Gent D.C., Chen D.J., Perlmann T. Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair. Genes Dev. 2011, 25:2031-2040.
69. Ohkura N., Nagamura Y., Tsukada T. Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1. J. Cell. Biochem. 2008, 105:785-800.
70. Ball A.R., Yokomori K. Damage site chromatin: open or closed?. Curr. Opin. Cell Biol. 2011, 23:277-283.
71. Han Y.H., Cao X., Lin B., Lin F., Kolluri S.K., Stebbins J., Reed J.C., Dawson M.I., Zhang X.K. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene 2006, 25:2974-2986.
72. Masuyama N., Oishi K., Mori Y., Ueno T., Takahama Y., Gotoh Y. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J. Biol. Chem. 2001, 276:32799-32805.
73. Wingate A.D., Campbell D.G., Peggie M., Arthur J.S. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem. J. 2006, 393:715-724.
74. Hirata Y., Kiuchi K., Chen H.C., Milbrandt J., Guroff G. The phosphorylation and DNA binding of the DNA-binding domain of the orphan nuclear receptor NGFI-B. J. Biol. Chem. 1993, 268:24808-24812.
75. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J., Croce C.M. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3690-3694.
76. Jacobs C.M., Boldingh K.A., Slagsvold H.H., Thoresen G.H., Paulsen R.E. ERK2 prohibits apoptosis-induced subcellular translocation of orphan nuclear receptor NGFI-B/TR3. J. Biol. Chem. 2004, 279:50097-50101.
77. Kolluri S.K., Bruey-Sedano N., Cao X., Lin B., Lin F., Han Y.H., Dawson M.I., Zhang X.K. Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell. Biol. 2003, 23:8651-8667.
78. Wang A., Rud J., Olson C.M., Anguita J., Osborne B.A. Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J. Immunol. 2009, 183:3268-3277.
79. Thompson J., Burger M.L., Whang H., Winoto A. Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis. Eur. J. Immunol. 2010, 40:2041-2049.
80. Kim H., Kim B.Y., Soh J.W., Cho E.J., Liu J.O., Youn H.D. A novel function of Nur77: physical and functional association with protein kinase C. Biochem. Biophys. Res. Commun. 2006, 348:950-956.
81. Castro-Obregon S., Rao R.V., del R.G., Chen S.F., Poksay K.S., Rabizadeh S., Vesce S., Zhang X.K., Swanson R.A., Bredesen D.E. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77. J. Biol. Chem. 2004, 279:17543-17553.
82. Slagsvold H.H., Ostvold A.C., Fallgren A.B., Paulsen R.E. Nuclear receptor and apoptosis initiator NGFI-B is a substrate for kinase ERK2. Biochem. Biophys. Res. Commun. 2002, 291:1146-1150.
83. Fujii Y., Matsuda S., Takayama G., Koyasu S. ERK5 is involved in TCR-induced apoptosis through the modification of Nur77. Genes Cells 2008, 13:411-419.
84. Yao L.M., He J.P., Chen H.Z., Wang Y., Wang W.J., Wu R., Yu C.D., Wu Q. Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis. Carcinogenesis 2012, 33:301-311.
85. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011, 25:1895-1908.
86. Close A.F., Rouillard C., Buteau J. NR4A orphan nuclear receptors in glucose homeostasis: a minireview. Diabetes Metab. 2013, 39:478-484.
87. Zhan Y.Y., Chen Y., Zhang Q., Zhuang J.J., Tian M., Chen H.Z., Zhang L.R., Zhang H.K., He J.P., Wang W.J., Wu R., Wang Y., Shi C., Yang K., Li A.Z., Xin Y.Z., Li T.Y., Yang J.Y., Zheng Z.H., Yu C.D., Lin S.C., Chang C., Huang P.Q., Lin T., Wu Q. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat. Chem. Biol. 2012, 8:897-904.
88. Xie Z., Dong Y., Zhang M., Cui M.Z., Cohen R.A., Riek U., Neumann D., Schlattner U., Zou M.H. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 2006, 281:6366-6375.
89. Wallen A.A., Castro D.S., Zetterstrom R.H., Karlen M., Olson L., Ericson J., Perlmann T. Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 2001, 18:649-663.
90. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995, 81:541-550.
91. Carpentier R., Sacchetti P., Segard P., Staels B., Lefebvre P. The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1. J. Neurochem. 2008, 104:777-789.
92. Sacchetti P., Carpentier R., Segard P., Olive-Cren C., Lefebvre P. Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1. Nucleic Acids Res. 2006, 34:5515-5527.
93. Zhang T., Jia N., Fei E., Wang P., Liao Z., Ding L., Yan M., Nukina N., Zhou J., Wang G. Nurr1 is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SH-SY5Y cells. Neurosci. Lett. 2007, 423:118-122.
94. Joseph B., Wallen-Mackenzie A., Benoit G., Murata T., Joodmardi E., Okret S., Perlmann T. p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15619-15624.
95. Jacobs F.M., van E.S., van der Linden A.J., von O.L., Burbach J.P., Smidt M.P. Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression. Development 2009, 136:531-540.
96. Kitagawa H., Ray W.J., Glantschnig H., Nantermet P.V., Yu Y., Leu C.T., Harada S., Kato S., Freedman L.P. A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling. Mol. Cell. Biol. 2007, 27:7486-7496.
97. Sekiya T., Kashiwagi I., Inoue N., Morita R., Hori S., Waldmann H., Rudensky A.Y., Ichinose H., Metzger D., Chambon P., Yoshimura A. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat. Commun. 2011, 2:269.
98. Saijo K., Winner B., Carson C.T., Collier J.G., Boyer L., Rosenfeld M.G., Gage F.H., Glass C.K. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137:47-59.
99. Arredondo C., Orellana M., Vecchiola A., Pereira L.A., Galdames L., Andres M.E. PIASgamma enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy. PLoS One 2013, 8:e55035.
100. Galleguillos D., Vecchiola A., Fuentealba J.A., Ojeda V., Alvarez K., Gomez A., Andres M.E. PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J. Biol. Chem. 2004, 279:2005-2011.
101. Zhang T., Wang P., Ren H., Fan J., Wang G. NGFI-B nuclear orphan receptor Nurr1 interacts with p53 and suppresses its transcriptional activity. Mol. Cancer Res. 2009, 7:1408-1415.
102. Albers M., Kranz H., Kober I., Kaiser C., Klink M., Suckow J., Kern R., Koegl M. Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol. Cell. Proteomics 2005, 4:205-213.
103. Codina A., Benoit G., Gooch J.T., Neuhaus D., Perlmann T., Schwabe J.W. Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting. J. Biol. Chem. 2004, 279:53338-53345.
104. Wansa K.D., Harris J.M., Yan G., Ordentlich P., Muscat G.E. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J. Biol. Chem. 2003, 278:24776-24790.
105. Wansa K.D., Muscat G.E. TRAP220 is modulated by the antineoplastic agent 6-mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors. J. Mol. Endocrinol. 2005, 34:835-848.
106. Cheng L.E., Chan F.K., Cado D., Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 1997, 16:1865-1875.
107. Ohkura N., Ohkubo T., Maruyama K., Tsukada T., Yamaguchi K. The orphan nuclear receptor NOR-1 interacts with the homeobox containing protein Six3. Dev. Neurosci. 2001, 23:17-24.
108. Laflamme C., Filion C., Bridge J.A., Ladanyi M., Goldring M.B., Labelle Y. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res. 2003, 63:449-454.